Emerging evidence indicates that PFAS exposure during childhood can affect bone development in adolescence, raising concerns about the long-term health effects of these persistent environmental chemicals.
A new study published in the Journal of the Endocrine Society reports an association between early exposure to per- and polyfluoroalkyl substances (PFAS) and decreased bone density in teenagers.
The researchers found that the timing of exposure may play an important role, as certain developmental stages appear to be more sensitive than others.
This research was funded by the National Institute of Environmental Health Sciences.
Tracking PFAS exposure throughout childhood
PFAS are a large class of synthetic compounds widely used in industrial processes and consumer products such as food packaging, nonstick cookware, and water-resistant materials.
Often referred to as eternal chemicals, these are difficult to break down and can accumulate in both the environment and human tissues.
To examine potential health effects, researchers analyzed data from 218 participants enrolled in a longitudinal birth cohort study.
Blood samples were collected at multiple time points: birth, 3, 8, and 12 years of age.
Bone mineral density was assessed at 12 years of age, focusing on markers related to skeletal strength during adolescence.
Key findings regarding bone density
This analysis confirmed a consistent association between high levels of perfluorooctanoic acid (PFOA), a common PFAS, and decreased bone density in the forearm. This relationship suggests that PFAS exposure may interfere with bone mineralization during critical growth stages.
For other PFAS compounds, the results were less uniform. The association with bone mineral density varied by time of exposure, indicating that susceptibility may vary by developmental stage.
Of note, stronger correlations were observed in female participants compared to male participants in this study, pointing to a possible gender-specific effect.
Impact on lifelong bone health
Adolescence is widely recognized to be a critical period for building peak bone mass, which is a major determinant of fracture risk and osteoporosis later in life. Disruption at this stage can have lasting effects on skeletal health.
This finding contributes to a growing body of research linking PFAS exposure to developmental and metabolic outcomes. Although the mechanisms are still being studied, previous research suggests that PFAS may interfere with hormonal pathways involved in growth and bone formation.
Consideration for the environment and public health
PFAS residues in drinking water and consumer products continue to pose a challenge to regulators and public health officials. This study adds to the evidence base supporting efforts to limit exposure, particularly during pregnancy and childhood.
Although this study does not establish a causal relationship, it highlights the need for further longitudinal studies to determine how PFAS exposure affects biological systems over time.
It also highlights the importance of identifying vulnerable periods during development when interventions are likely to be most effective.
Source link
